197 related articles for article (PubMed ID: 27561170)
1. Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors.
Mitchell AP; Basch EM; Dusetzina SB
JAMA Oncol; 2016 Dec; 2(12):1628-1631. PubMed ID: 27561170
[TBL] [Abstract][Full Text] [Related]
2. Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019.
Desai AP; Chengappa M; Go RS; Poonacha TK
Cancer; 2020 Aug; 126(16):3742-3749. PubMed ID: 32497271
[TBL] [Abstract][Full Text] [Related]
3. Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines.
Liu X; Tang LL; Mao YP; Liu Q; Sun Y; Chen L; Lin JC; Ma J
Oncologist; 2019 Apr; 24(4):498-504. PubMed ID: 30459237
[TBL] [Abstract][Full Text] [Related]
4. Financial Conflicts of Interest Among Authors of Clinical Practice Guidelines for Routine Screening Mammography.
Combs T; Tritz D; Ivy H; von Borstel D; Horn J; Vassar M
J Am Coll Radiol; 2019 Nov; 16(11):1598-1603. PubMed ID: 31152689
[TBL] [Abstract][Full Text] [Related]
5. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs.
Tibau A; Bedard PL; Srikanthan A; Ethier JL; Vera-Badillo FE; Templeton AJ; Ocaña A; Seruga B; Barnadas A; Amir E
J Clin Oncol; 2015 Jan; 33(1):100-6. PubMed ID: 25385736
[TBL] [Abstract][Full Text] [Related]
6. Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines.
Saleh RR; Majeed H; Tibau A; Booth CM; Amir E
Cancer; 2019 Nov; 125(22):4069-4075. PubMed ID: 31355923
[TBL] [Abstract][Full Text] [Related]
7. Undisclosed payments by pharmaceutical and medical device manufacturers to authors of endoscopy guidelines in the United States.
Bansal R; Khan R; Scaffidi MA; Gimpaya N; Genis S; Bukhari A; Dhillon J; Dao K; Bonneau C; Grover SC
Gastrointest Endosc; 2020 Feb; 91(2):266-273. PubMed ID: 31738925
[TBL] [Abstract][Full Text] [Related]
8. Financial conflicts of interest of OncoAlert: An informal oncology professional network.
Powell K; Kakkilaya A; Haslam A; Prasad V
J Cancer Policy; 2022 Dec; 34():100369. PubMed ID: 36396090
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T
JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027
[TBL] [Abstract][Full Text] [Related]
10. Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
Mitchell AP; Mishra A; Dey P; Curry MA; Trivedi NU; Haddadin M; Rahman MW; Winn AN; Dusetzina SB; Bach PB
Oncologist; 2021 Sep; 26(9):771-778. PubMed ID: 33982829
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.
Murayama A; Ozaki A; Saito H; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T
PLoS One; 2020; 15(10):e0239610. PubMed ID: 33048952
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.
Checketts JX; Sims MT; Vassar M
JAMA Dermatol; 2017 Dec; 153(12):1229-1235. PubMed ID: 29049553
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines.
Horn J; Checketts JX; Jawhar O; Vassar M
JAMA Otolaryngol Head Neck Surg; 2018 Mar; 144(3):194-201. PubMed ID: 29270633
[TBL] [Abstract][Full Text] [Related]
14. Financial Relationships With Industry of Editorial Board Members of the Three Journals of the American Society for Radiation Oncology.
Verma V
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):286-291. PubMed ID: 28871971
[TBL] [Abstract][Full Text] [Related]
15. Industry compensation and self-reported financial conflicts of interest among authors of highly cited peripheral artery disease studies.
Bellomo TR; Hwang C; Spector-Bagdady K; Stanley JC; Corriere MA
J Vasc Surg; 2020 Aug; 72(2):673-684. PubMed ID: 31980241
[TBL] [Abstract][Full Text] [Related]
16. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.
Shnier A; Lexchin J; Romero M; Brown K
BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247
[TBL] [Abstract][Full Text] [Related]
17. Financial relationships between industry and principal investigators of US cooperative group randomized cancer clinical trials.
Metzger AL; Kusi Appiah A; Wright CM; Jairam V; Amini A; Park HS; Welsh JW; Thomas CR; Verma V; Ludmir EB
Int J Cancer; 2021 Nov; 149(9):1683-1690. PubMed ID: 34173669
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Financial Conflicts of Interest and Quality of Evidence Underlying the American Diabetes Association Clinical Practice Guidelines: The Standards of Medical Care in Diabetes, 2021.
Shigeta H; Murayama A; Kamamoto S; Saito H; Ozaki A
Cureus; 2023 Mar; 15(3):e36567. PubMed ID: 37095789
[TBL] [Abstract][Full Text] [Related]
19. Authors of clinical trials seldom reported details when declaring their individual and institutional financial conflicts of interest: a cross-sectional survey.
Hakoum MB; Noureldine H; Habib JR; Abou-Jaoude EA; Raslan R; Jouni N; Hasbani DJ; Lopes LC; Guyatt G; Akl EA
J Clin Epidemiol; 2020 Nov; 127():49-58. PubMed ID: 32512186
[TBL] [Abstract][Full Text] [Related]
20. Financial Disclosures Reported by Industry Among Authors of the American Academy of Ophthalmology Clinical Practice Guidelines.
Nguyen AX; Joly-Chevrier M; Nguyen DD; Wu AY
JAMA Ophthalmol; 2023 Apr; 141(4):378-383. PubMed ID: 36928457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
